206 related articles for article (PubMed ID: 25722570)
1. Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods.
Kaur D; Sharma RR; Marwaha N
Asian J Transfus Sci; 2015; 9(1):31-5. PubMed ID: 25722570
[TBL] [Abstract][Full Text] [Related]
2. Cytokine generation in stored platelet concentrate: comparison of two methods of preparation.
Chaudhary R; Aggarwal A; Khetan D; Dayal R
Indian J Med Res; 2006 Oct; 124(4):427-30. PubMed ID: 17159263
[TBL] [Abstract][Full Text] [Related]
3. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
Singh RP; Marwaha N; Malhotra P; Dash S
Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
[TBL] [Abstract][Full Text] [Related]
4. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays.
Wadhwa M; Seghatchian MJ; Lubenko A; Contreras M; Dilger P; Bird C; Thorpe R
Br J Haematol; 1996 Apr; 93(1):225-34. PubMed ID: 8611466
[TBL] [Abstract][Full Text] [Related]
5. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
Muylle L; Wouters E; Peetermans ME
Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
[TBL] [Abstract][Full Text] [Related]
6. Serial changes in morphology and biochemical markers in platelet preparations with storage.
Jain A; Marwaha N; Sharma RR; Kaur J; Thakur M; Dhawan HK
Asian J Transfus Sci; 2015; 9(1):41-7. PubMed ID: 25722572
[TBL] [Abstract][Full Text] [Related]
7. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study.
Toora E; Kulkarni RG; Manivannan P; Sastry AS; Basavarajegowda A; Sahoo D
Asian J Transfus Sci; 2023; 17(2):239-245. PubMed ID: 38274963
[TBL] [Abstract][Full Text] [Related]
8. Time Dependent Release of Interleukin-8 and Tumor Necrosis Factor-α in Platelet Concentrate.
Shukla RV; Patel TG; Gupte SC
Indian J Hematol Blood Transfus; 2015 Jun; 31(2):259-63. PubMed ID: 25825569
[TBL] [Abstract][Full Text] [Related]
9. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients.
Singh RP; Marwaha N; Malhotra P; Dash S
Indian J Hematol Blood Transfus; 2008 Mar; 24(1):16-22. PubMed ID: 23100935
[TBL] [Abstract][Full Text] [Related]
11. Generation of IL-8 and TNF-alpha in platelet concentrates during storage.
Shaiegan M; Pourfatollah AA; Namiri M; Babaee G
Arch Iran Med; 2006 Jan; 9(1):61-4. PubMed ID: 16649381
[TBL] [Abstract][Full Text] [Related]
12. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates.
Weisbach V; Wanke C; Zingsem J; Zimmermann R; Eckstein R
Vox Sang; 1999; 76(2):100-6. PubMed ID: 10085526
[TBL] [Abstract][Full Text] [Related]
13. White cell apoptosis in platelet concentrates.
Frabetti F; Tazzari PL; Musiani D; Bontadini A; Matteini C; Roseti L; Tassi C; Viggiani M; Marini M; Conte R
Transfusion; 2000 Feb; 40(2):160-8. PubMed ID: 10685999
[TBL] [Abstract][Full Text] [Related]
14. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the level of cytokine mRNA in buffy coat-derived platelet concentrates prepared with or without white cell reduction by filtration.
Christensen LL; Grunnet N; Rüdiger N
Transfusion; 1998 Mar; 38(3):236-41. PubMed ID: 9563402
[TBL] [Abstract][Full Text] [Related]
16. Buffy coat pooled platelet concentrate: A new age platelet component.
Kumar R; Dhawan HK; Sharma RR; Kaur J
Asian J Transfus Sci; 2021; 15(2):125-132. PubMed ID: 34908742
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1 beta and tumor necrosis factor levels in stored platelet concentrates and the association with gene polymorphisms.
Addas-Carvalho M; Origa AF; Saad ST
Transfusion; 2004 Jul; 44(7):996-1003. PubMed ID: 15225239
[TBL] [Abstract][Full Text] [Related]
18. Low cytokine contamination in buffy coat-derived platelet concentrates without filtration.
Flegel WA; Wiesneth M; Stampe D; Koerner K
Transfusion; 1995; 35(11):917-20. PubMed ID: 8604488
[TBL] [Abstract][Full Text] [Related]
19. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
